Virpax Pharmaceuticals

Virpax Pharmaceuticals Announces Leadership Changes; Gerald Bruce Appointed CEO, Dr. Eric Floyd Named Chairman

BERWYN, PA — Virpax® Pharmaceuticals, Inc. (NASDAQ: VRPX), a company specializing in non-opioid pain management therapies, has announced significant changes to its leadership team amidst ongoing litigation. The company recently …

Virpax Pharmaceuticals Announces Leadership Changes; Gerald Bruce Appointed CEO, Dr. Eric Floyd Named Chairman Read More


Neuronetics, Inc

Neuronetics Unveils Major Updates to NeuroStar and TrakStar Software for Enhanced Patient Care and Data Management

MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) announced this week significant updates to its proprietary NeuroStar software and TrakStar® Patient Data Management System. These enhancements aim to revolutionize patient care …

Neuronetics Unveils Major Updates to NeuroStar and TrakStar Software for Enhanced Patient Care and Data Management Read More

Aclaris Therapeutics

Aclaris Therapeutics Halts Development of Rheumatoid Arthritis Drug After Phase 2b Study Misses Primary Endpoint

WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) this week announced disappointing top-line results from a Phase 2b study of zunsemetinib (ATI-450) in patients with moderate to severe rheumatoid arthritis …

Aclaris Therapeutics Halts Development of Rheumatoid Arthritis Drug After Phase 2b Study Misses Primary Endpoint Read More